Search Orphan Drug Designations and Approvals
-
| Generic Name: | Iobenguane I 123 |
|---|---|
| Trade Name: | Adreview |
| Date Designated: | 12/01/2006 |
| Orphan Designation: | For the diagnosis of neuroblastomas |
| Orphan Designation Status: | Designated/Approved |
| Marketing Approval Date: | 09/19/2008 |
| Approved Labeled Indication: | To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests |
| Exclusivity End Date: | 09/19/2015 |
| Exclusivity Protected Indication* : | |
| Sponsor: |
GE Healthcare, Inc. 101 Carnegie Center Princeton, New Jersey 08540 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
